Myriad Illumina, Merck Partner to Advance Homologous Recombination Deficiency CDx, Research Assay Under the terms of the deal, Illumina will develop a new HRD CDx for the EU and UK markets and a research-use only HRD assay that will be add-on content for its TSO 500 panel. GenomeWeb Index up Slightly in August as Guardant Health Leads on Strength of Q2 Earnings The GenomeWeb Index outperformed the Dow Jones last month, but underperformed the Nasdaq and the Nasdaq Biotechnology Index. Noviscend Inks Canadian Distribution Deal for Myriad Genetics Tests The deal covers a range of Myriad's tests including risk assessment tests for breast, prostate, and other cancers. New Products Posted to GenomeWeb: HTG Molecular, Myriad Genetics, Eclipse Bioinnovations, More Myriad Genetics More Than Doubles Quarterly Revenues Although the firm is still not providing a full-year revenue estimate due to COVID-19 uncertainties, its hereditary cancer testing segment is driving strong sales growth for the firm. Jun 5, 2021 Myriad Genetics Recalibrates Breast Cancer PRS for All Ancestries in Anticipation of Broader Launch Premium May 24, 2021 Myriad Genetics Sells Pharma Research Services Business to Q2 Solutions May 5, 2021 Myriad Genetics Projects Return to Profitability by Year End, Details Long-Term Growth Plan Premium May 3, 2021 Myriad Genetics' Quarterly Revenues Increase 6 Percent May 3, 2021 Labcorp to Acquire Myriad Genetics' Vectra Rheumatoid Arthritis Test for $150M Apr 27, 2021 Castle Biosciences Acquires Myriad Genetics' MyPath Melanoma Test, Lab for $32.5M Mar 24, 2021 Intermountain Gets National Stage, Myriad Adds Tumor Profiling Panel With Combined Test Offering Premium Mar 2, 2021 Myriad Genetics, Intermountain Healthcare Collaborate for Cancer Testing Service Feb 23, 2021 Myriad Genetics Quarterly Revenues Decline 21 Percent Feb 19, 2021 People in the News: Peer Schatz Board Appointments at Siemens, Centogene; More Jan 12, 2021 JP Morgan Healthcare Conference 2021, Day 2: Roche, Seer, 10x, Guardant, Hologic, Thermo Fisher Jan 11, 2021 Illumina CEO Discusses Pan-Cancer IVD Assay, CDx Collaborations at JP Morgan Jan 5, 2021 Myriad Genetics to Sell Vectra DA Business, Reorganize International Presence Jan 5, 2021 GenomeWeb Index Gains 49 Percent in 2020, Outperforming Wider Markets Dec 9, 2020 Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project Dec 1, 2020 Veracyte, Twist Bioscience Lead November GenomeWeb Index on Strong Earnings Growth Nov 16, 2020 Myriad Genetics Expands MyChoice CDx Access Through Partnerships in Europe, China Nov 16, 2020 Myriad Genetics Bets Fetal DNA Enrichment Method Will Further Increase Uptake of NIPS Test Premium Nov 9, 2020 Myriad Genetics Quarterly Revenues Down 22 Percent Oct 15, 2020 Germany Grants National Reimbursement for Three Additional Breast Cancer Biomarker Tests Load More Breaking News Ancient DNA Analysis Highlights Three Ancestral Populations in Japan FDA Warns of Potential False Positives With Abbott SARS-CoV-2 Molecular Tests New Products Posted to GenomeWeb: Oxford Nanopore, Beckman Coulter, Thermo Fisher Scientific, More People in the News: New Appointments at Sema4, NHGRI, Dante Labs, Ancestry, More Thermo Fisher Scientific Expects 12 Percent Revenue Growth in 2022 In Brief This Week: Myriad Genetics, Danaher, Co-Diagnostics, and More The Scan For Those Thick Tiger Stripes Tigers in India with thick stripes harbor a genetic change, as Gizmodo reports. High GABA Tomatoes The Japan News reports that genome-edited tomatoes with higher GABA levels are now for sale in Japan. Approach for Inclusivity and Diversity A National Human Genome Research Institute team calls for the field to "adopt diversity as an ethos." Science Papers on Tumors Immune System Evasion; Drivers of Genomic Instability, Inflammation In Science this week: study of how tumors evade the adaptive immune system, and more.